Author

H. Bharadwaj

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors

Advanced EGFR-mutant non-small cell lung cancer (NSCLC), specifically tumors harboring classical activating mutations (exon 19 deletions and L858R substitutions, which are the exclusive focus of this review), is no longer a single-treatment landscape. The MARIPOSA and FLAURA2 phase 3 trials have established that combin...

Ashish Sharma, J. Tan, Harendra Kumar et al. · Medical Oncology · 0 citations

Review Open access Aug 2026

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023–2026 evidence and a proposed clinical integration framework

A narrative review synthesizes evidence published between 2020 and 2026 within a unified clinical framework not provided by prior reviews, and proposes an original biomarker-guided clinical algorithm, a comparative clinical readiness table, and a disease-continuum biomarker timeline as practical tools for clinicians an...

Ashish Sharma, J. Tan, Rajvardhan Sisodia et al. · Frontiers in Oncology · 0 citations